- Home
- BIVI vs KXIN Comparison
BIVI vs KXIN Comparison
Compare BIVI & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- KXIN
- Stock Information
- Founded
- BIVI 2013
- KXIN 2015
- Country
- BIVI United States
- KXIN China
- Employees
- BIVI N/A
- KXIN N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- BIVI Health Care
- KXIN Consumer Discretionary
- Exchange
- BIVI Nasdaq
- KXIN Nasdaq
- Market Cap
- BIVI 15.1M
- KXIN 13.0M
- IPO Year
- BIVI N/A
- KXIN N/A
- Fundamental
- Price
- BIVI $1.08
- KXIN $0.94
- Analyst Decision
- BIVI Strong Buy
- KXIN
- Analyst Count
- BIVI 1
- KXIN 0
- Target Price
- BIVI $30.00
- KXIN N/A
- AVG Volume (30 Days)
- BIVI 821.9K
- KXIN 118.5K
- Earning Date
- BIVI 05-12-2025
- KXIN 01-01-0001
- Dividend Yield
- BIVI N/A
- KXIN N/A
- EPS Growth
- BIVI N/A
- KXIN N/A
- EPS
- BIVI N/A
- KXIN N/A
- Revenue
- BIVI N/A
- KXIN N/A
- Revenue This Year
- BIVI N/A
- KXIN N/A
- Revenue Next Year
- BIVI N/A
- KXIN N/A
- P/E Ratio
- BIVI N/A
- KXIN N/A
- Revenue Growth
- BIVI N/A
- KXIN N/A
- 52 Week Low
- BIVI $0.62
- KXIN $0.64
- 52 Week High
- BIVI $7.50
- KXIN $29.52
- Technical
- Relative Strength Index (RSI)
- BIVI 53.44
- KXIN 48.23
- Support Level
- BIVI $1.05
- KXIN $0.85
- Resistance Level
- BIVI $1.29
- KXIN $1.11
- Average True Range (ATR)
- BIVI 0.14
- KXIN 0.08
- MACD
- BIVI 0.02
- KXIN 0.01
- Stochastic Oscillator
- BIVI 52.19
- KXIN 35.50
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.